Back
PT Bank Central Asia Tbk Vs. Keros Therapeutics Industry Stock Comparison
Buy
68
PBCRF
PT Bank Central Asia Tbk
Last Price:
0.72
Seasonality Move:
10.62%
Buy
68
KROS
Keros Therapeutics
Last Price:
59.23
Seasonality Move:
45.94%
Buy
68
PT Bank Central Asia Tbk (PBCRF)
is a Buy
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
- The current PT Bank Central Asia Tbk [PBCRF] share price is $0.72. The Score for PBCRF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- PBCRF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $59.33. The Score for KROS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBCRF is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $59.33
The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 56.62 | Buy |
Chaikin Money Flow: | 5266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.67 - 0.71) | Buy |
Bollinger Bands (100): | (0.59 - 0.69) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.74 | Buy |
Relative Strength Index (14 RSI): | 54.42 | Buy |
Chaikin Money Flow: | -73900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.33 - 60.71) | Buy |
Bollinger Bands (100): | (44.91 - 56.17) | Buy |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.7 | Buy |
20-day SMA: | 0.69 | Buy |
50-day SMA: | 0.68 | Buy |
200-day SMA: | 0.62 | Buy |
8-day EMA: | 0.71 | Buy |
20-day EMA: | 0.69 | Buy |
50-day EMA: | 0.67 | Buy |
200-day EMA: | 0.63 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.18 | Sell |
20-day SMA: | 59.23 | Buy |
50-day SMA: | 53.7 | Buy |
200-day SMA: | 54.65 | Buy |
8-day EMA: | 60.13 | Sell |
20-day EMA: | 58.89 | Buy |
50-day EMA: | 55.53 | Buy |
200-day EMA: | 51.4 | Buy |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.47 per share.
PT Bank Central Asia Tbk Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |